Titan Pharmaceuticals Inc (TTNP)

[interstate]

I like this part of the proxy. This means they have already been in talk with the NASDAQ exchange.

Our common stock is currently quoted on the OTC Market. We have applied for listing on the NASDAQ Stock Market (“NASDAQ”). The initial listing criteria for NASDAQ’s Capital Market requires a minimum closing price of $3.00 per share. Our goal, through the Reverse Split, is to increase our stock price so that it enables us to satisfy the NASDAQ listing standards. We also believe that a higher stock price will make our company more attractive to a broader range of investors, including professional investors, institutional investors and the general investing public